Pixee Medical
Generated 5/9/2026
Executive Summary
Pixee Medical is a French medtech company pioneering augmented reality (AR) solutions for orthopedic surgery, with its flagship Knee+ NexSight system designed for total knee arthroplasty (TKA). Founded in 2017 and based in Besançon, the company aims to enhance surgical accuracy and efficiency through an ultra-compact, surgeon-controlled AR platform that integrates seamlessly into existing workflows, requiring minimal training and no bulky capital equipment. Having already achieved regulatory approval in certain markets, Pixee Medical is positioned to disrupt the orthopedic navigation market by offering a more accessible and cost-effective alternative to traditional robotic and computer-assisted systems. The company targets the growing demand for minimally invasive and personalized orthopedic procedures, with potential for expansion into other AR-guided surgeries. However, competitive pressure from established players and the need for clinical evidence to drive adoption remain key challenges.
Upcoming Catalysts (preview)
- Q4 2026FDA 510(k) clearance for Knee+ NexSight in the US market70% success
- Q2 2027Publication of pivotal clinical study results demonstrating improved outcomes vs conventional TKA80% success
- H1 2027Strategic partnership with a major orthopedic implant manufacturer for global distribution50% success
- · Pipeline Analysis
- · Competitive Landscape
- · Catalyst Calendar (full 12-month)
- · Bull Case
- · Bear Case
- · Counterfactual Scenarios
- · Valuation Notes
- · SEC Filing Highlights
- · Insider Activity
- · Literature Watch
- · Patent Landscape
- · Mechanism Cluster Map
- · Audio Briefing (5 min)